A day-long conference on national security secrecy will be held tomorrow, October 16, at Fordham Law School in New York City.
The conference brings together a promising mix of former government officials, journalists, litigators, academics and others, including myself.
For more information on the conference, which is open to the public, see here.
Nuclear weapons budgeting is like agreeing to buying a house without knowing the sales price, the mortgage rate, or the monthly payment.
Employing a living approach to evidence synthesis, disseminated at a national level, is a streamlined way to enable evidence-based decision-making nationwide.
By providing essential funding mechanisms, the Bioeconomy Finance Program will reduce the risks inherent in biotechnology innovation, encouraging more private sector investment.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.